MARKET

INGN

INGN

Inogen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

54.03
+1.53
+2.91%
After Hours: 54.03 0 0.00% 16:34 04/09 EDT
OPEN
52.50
PREV CLOSE
52.50
HIGH
54.27
LOW
52.17
VOLUME
134.77K
TURNOVER
--
52 WEEK HIGH
56.46
52 WEEK LOW
26.57
MARKET CAP
1.20B
P/E (TTM)
-203.1203
1D
5D
1M
3M
1Y
5Y
Oxygen Therapy Device Industry Share, Size 2021 Global Market Growth, Top Manufacturers, Trends, Revenue, Revenue, Demand and Applications Research Report Forecast to 2026
Apr 11, 2021 (The Expresswire) -- Global “Oxygen Therapy Device Market” research report provides the newest industry data and industry future trends,...
The Express Wire · 10h ago
Homecare Oxygen Concentrators Market with Industry Growth Analysis 2021: Latest Trends and Challenges, Application Segment and Geographical Landscape Forecast to 2024 with Global Impact of Covid-19
Apr 08, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Homecare Oxygen Concentrators...
The Express Wire · 3d ago
Portable Oxygen Concentrators Market 2021 SWOT Study, PESTEL Analysis, Competitive Landscape, Segmentation|Koninklijke Philips N.V, Inogen Inc, Chart Industries Inc.
Apr 08, 2021 (WiredRelease via Comtex) -- The studies on worldwide Portable Oxygen Concentrators market evaluate the capabilities, organizations,...
marketresearch.biz · 3d ago
Inogen Announces Appointment of Chief Commercial Officer, Transition of Certain Officers, and Preliminary, Unaudited First Quarter 2021 Revenue Range
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed George Parr as Inogen's Executive Vice President and Chief Commerc...
BusinessWire · 4d ago
8-K: Inogen Inc
(EDGAR Online via COMTEX) -- false 0001294133 0001294133 2021-04-02 2021-04-02 0001294133 dei:FormerAddressMember 2021-04-02 2021-04-02 UNITED STATES...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 4d ago
BRIEF-Inogen Inc Says George Parr To Join As Executive Vice President And Chief Commercial Officer Effective April 12, 2021
reuters.com · 4d ago
Inogen Sees 1Q Rev $84M-$87M >INGN
Inogen Sees 1Q Rev $84M-$87M >INGN
Dow Jones · 4d ago
Inogen Names George Parr Chief Commercial Officer Effective April 12 >INGN
Inogen Names George Parr Chief Commercial Officer Effective April 12 >INGN
Dow Jones · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of INGN. Analyze the recent business situations of Inogen through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average INGN stock price target is 54.33 with a high estimate of 60.00 and a low estimate of 49.00.
EPS
Institutional Holdings
Institutions: 294
Institutional Holdings: 23.42M
% Owned: 105.28%
Shares Outstanding: 22.25M
TypeInstitutionsShares
Increased
46
806.46K
New
28
407.70K
Decreased
54
1.35M
Sold Out
19
349.15K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.13%
Healthcare Equipment & Supplies
+1.08%
Key Executives
Non-Executive Chairman/Independent Director
Heath Lukatch
President/Chief Executive Officer/Director
Nabil Shabshab
Co-Founder/Chief Financial Officer/Executive Vice President - Finance/Treasurer/Secretary
Alison Bauerlein
Co-Founder/Executive Vice President
Brenton Taylor
Executive Vice President
Bart Sanford
Independent Director
Benjamin Anderson-Ray
Independent Director
R. Scott Greer
Independent Director
Raymond Huggenberger
Independent Director
Loren McFarland
Independent Director
Kristen Miranda
Independent Director
Heather Rider
No Data
About INGN
Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Webull offers kinds of Inogen Inc stock information, including NASDAQ:INGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INGN stock methods without spending real money on the virtual paper trading platform.